nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylephrine—Extravasation—Carboplatin—bone cancer	0.0609	0.0615	CcSEcCtD
Phenylephrine—Skin necrosis—Cisplatin—bone cancer	0.0446	0.045	CcSEcCtD
Phenylephrine—Skin necrosis—Methotrexate—bone cancer	0.0245	0.0247	CcSEcCtD
Phenylephrine—Skin necrosis—Epirubicin—bone cancer	0.0229	0.0231	CcSEcCtD
Phenylephrine—Sensitisation—Epirubicin—bone cancer	0.0224	0.0226	CcSEcCtD
Phenylephrine—Skin necrosis—Doxorubicin—bone cancer	0.0212	0.0214	CcSEcCtD
Phenylephrine—Rales—Methotrexate—bone cancer	0.0208	0.021	CcSEcCtD
Phenylephrine—Sensitisation—Doxorubicin—bone cancer	0.0207	0.0209	CcSEcCtD
Phenylephrine—Extravasation—Cisplatin—bone cancer	0.0179	0.018	CcSEcCtD
Phenylephrine—Pain—Carboplatin—bone cancer	0.0162	0.0164	CcSEcCtD
Phenylephrine—Skin exfoliation—Cisplatin—bone cancer	0.0149	0.015	CcSEcCtD
Phenylephrine—Lacrimation—Epirubicin—bone cancer	0.0136	0.0137	CcSEcCtD
Phenylephrine—Lacrimation—Doxorubicin—bone cancer	0.0126	0.0127	CcSEcCtD
Phenylephrine—Keratitis—Epirubicin—bone cancer	0.0123	0.0125	CcSEcCtD
Phenylephrine—Keratitis—Doxorubicin—bone cancer	0.0114	0.0115	CcSEcCtD
Phenylephrine—Ventricular arrhythmia—Epirubicin—bone cancer	0.0108	0.0109	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Cisplatin—bone cancer	0.0103	0.0104	CcSEcCtD
Phenylephrine—Ventricular arrhythmia—Doxorubicin—bone cancer	0.01	0.0101	CcSEcCtD
Phenylephrine—Stinging—Epirubicin—bone cancer	0.00988	0.00997	CcSEcCtD
Phenylephrine—Extravasation—Methotrexate—bone cancer	0.0098	0.0099	CcSEcCtD
Phenylephrine—Sweating increased—Cisplatin—bone cancer	0.00952	0.00962	CcSEcCtD
Phenylephrine—Extravasation—Epirubicin—bone cancer	0.00917	0.00926	CcSEcCtD
Phenylephrine—Stinging—Doxorubicin—bone cancer	0.00914	0.00923	CcSEcCtD
Phenylephrine—Ventricular extrasystoles—Epirubicin—bone cancer	0.00886	0.00895	CcSEcCtD
Phenylephrine—Lacrimation increased—Epirubicin—bone cancer	0.00868	0.00877	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Cisplatin—bone cancer	0.00859	0.00868	CcSEcCtD
Phenylephrine—Myocardial infarction—Cisplatin—bone cancer	0.00854	0.00863	CcSEcCtD
Phenylephrine—Extravasation—Doxorubicin—bone cancer	0.00849	0.00857	CcSEcCtD
Phenylephrine—Atrioventricular block—Epirubicin—bone cancer	0.00825	0.00833	CcSEcCtD
Phenylephrine—Ventricular extrasystoles—Doxorubicin—bone cancer	0.0082	0.00828	CcSEcCtD
Phenylephrine—Skin exfoliation—Methotrexate—bone cancer	0.00816	0.00824	CcSEcCtD
Phenylephrine—Neck pain—Epirubicin—bone cancer	0.0081	0.00818	CcSEcCtD
Phenylephrine—Lacrimation increased—Doxorubicin—bone cancer	0.00803	0.00811	CcSEcCtD
Phenylephrine—Bradycardia—Cisplatin—bone cancer	0.00797	0.00804	CcSEcCtD
Phenylephrine—Skin exfoliation—Epirubicin—bone cancer	0.00764	0.00771	CcSEcCtD
Phenylephrine—Atrioventricular block—Doxorubicin—bone cancer	0.00763	0.00771	CcSEcCtD
Phenylephrine—Pulmonary oedema—Methotrexate—bone cancer	0.00761	0.00769	CcSEcCtD
Phenylephrine—Visual impairment—Cisplatin—bone cancer	0.00754	0.00762	CcSEcCtD
Phenylephrine—Neck pain—Doxorubicin—bone cancer	0.00749	0.00757	CcSEcCtD
Phenylephrine—Cardiac disorder—Cisplatin—bone cancer	0.00726	0.00733	CcSEcCtD
Phenylephrine—Pulmonary oedema—Epirubicin—bone cancer	0.00712	0.00719	CcSEcCtD
Phenylephrine—Skin exfoliation—Doxorubicin—bone cancer	0.00707	0.00714	CcSEcCtD
Phenylephrine—Immune system disorder—Cisplatin—bone cancer	0.00707	0.00714	CcSEcCtD
Phenylephrine—Mediastinal disorder—Cisplatin—bone cancer	0.00705	0.00712	CcSEcCtD
Phenylephrine—Arrhythmia—Cisplatin—bone cancer	0.00699	0.00706	CcSEcCtD
Phenylephrine—Salbutamol—CYP3A4—bone cancer	0.00666	0.689	CrCbGaD
Phenylephrine—Pulmonary oedema—Doxorubicin—bone cancer	0.00659	0.00666	CcSEcCtD
Phenylephrine—Visual disturbance—Methotrexate—bone cancer	0.00655	0.00661	CcSEcCtD
Phenylephrine—Eye pain—Epirubicin—bone cancer	0.00643	0.0065	CcSEcCtD
Phenylephrine—Vision blurred—Cisplatin—bone cancer	0.00642	0.00648	CcSEcCtD
Phenylephrine—Tremor—Cisplatin—bone cancer	0.00638	0.00644	CcSEcCtD
Phenylephrine—Eye pain—Doxorubicin—bone cancer	0.00595	0.00601	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.00576	0.00582	CcSEcCtD
Phenylephrine—Nervous system disorder—Cisplatin—bone cancer	0.00545	0.00551	CcSEcCtD
Phenylephrine—Tachycardia—Cisplatin—bone cancer	0.00543	0.00548	CcSEcCtD
Phenylephrine—Skin disorder—Cisplatin—bone cancer	0.0054	0.00545	CcSEcCtD
Phenylephrine—Hyperhidrosis—Cisplatin—bone cancer	0.00537	0.00543	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Epirubicin—bone cancer	0.00531	0.00536	CcSEcCtD
Phenylephrine—Abdominal pain upper—Epirubicin—bone cancer	0.00531	0.00536	CcSEcCtD
Phenylephrine—Paraesthesia—Cisplatin—bone cancer	0.00499	0.00504	CcSEcCtD
Phenylephrine—Dyspnoea—Cisplatin—bone cancer	0.00496	0.00501	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Doxorubicin—bone cancer	0.00491	0.00496	CcSEcCtD
Phenylephrine—Abdominal pain upper—Doxorubicin—bone cancer	0.00491	0.00496	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Cisplatin—bone cancer	0.0048	0.00485	CcSEcCtD
Phenylephrine—Pain—Cisplatin—bone cancer	0.00475	0.0048	CcSEcCtD
Phenylephrine—Visual impairment—Methotrexate—bone cancer	0.00414	0.00418	CcSEcCtD
Phenylephrine—Hypersensitivity—Cisplatin—bone cancer	0.0041	0.00414	CcSEcCtD
Phenylephrine—Bradycardia—Epirubicin—bone cancer	0.00409	0.00413	CcSEcCtD
Phenylephrine—Cardiac disorder—Methotrexate—bone cancer	0.00399	0.00402	CcSEcCtD
Phenylephrine—Angiopathy—Methotrexate—bone cancer	0.0039	0.00393	CcSEcCtD
Phenylephrine—Immune system disorder—Methotrexate—bone cancer	0.00388	0.00392	CcSEcCtD
Phenylephrine—Visual impairment—Epirubicin—bone cancer	0.00387	0.00391	CcSEcCtD
Phenylephrine—Mediastinal disorder—Methotrexate—bone cancer	0.00387	0.00391	CcSEcCtD
Phenylephrine—Bradycardia—Doxorubicin—bone cancer	0.00379	0.00382	CcSEcCtD
Phenylephrine—Mental disorder—Methotrexate—bone cancer	0.00376	0.0038	CcSEcCtD
Phenylephrine—Cardiac disorder—Epirubicin—bone cancer	0.00373	0.00377	CcSEcCtD
Phenylephrine—Dysgeusia—Methotrexate—bone cancer	0.00366	0.0037	CcSEcCtD
Phenylephrine—Angiopathy—Epirubicin—bone cancer	0.00365	0.00368	CcSEcCtD
Phenylephrine—Immune system disorder—Epirubicin—bone cancer	0.00363	0.00367	CcSEcCtD
Phenylephrine—Mediastinal disorder—Epirubicin—bone cancer	0.00362	0.00366	CcSEcCtD
Phenylephrine—Arrhythmia—Epirubicin—bone cancer	0.00359	0.00363	CcSEcCtD
Phenylephrine—Visual impairment—Doxorubicin—bone cancer	0.00358	0.00362	CcSEcCtD
Phenylephrine—Vomiting—Cisplatin—bone cancer	0.00353	0.00357	CcSEcCtD
Phenylephrine—Vision blurred—Methotrexate—bone cancer	0.00352	0.00356	CcSEcCtD
Phenylephrine—Mental disorder—Epirubicin—bone cancer	0.00352	0.00356	CcSEcCtD
Phenylephrine—Rash—Cisplatin—bone cancer	0.00351	0.00354	CcSEcCtD
Phenylephrine—Dermatitis—Cisplatin—bone cancer	0.0035	0.00354	CcSEcCtD
Phenylephrine—Cardiac disorder—Doxorubicin—bone cancer	0.00345	0.00348	CcSEcCtD
Phenylephrine—Tension—Epirubicin—bone cancer	0.00343	0.00347	CcSEcCtD
Phenylephrine—Dysgeusia—Epirubicin—bone cancer	0.00343	0.00346	CcSEcCtD
Phenylephrine—Nervousness—Epirubicin—bone cancer	0.0034	0.00343	CcSEcCtD
Phenylephrine—Angiopathy—Doxorubicin—bone cancer	0.00337	0.00341	CcSEcCtD
Phenylephrine—Immune system disorder—Doxorubicin—bone cancer	0.00336	0.00339	CcSEcCtD
Phenylephrine—Mediastinal disorder—Doxorubicin—bone cancer	0.00335	0.00338	CcSEcCtD
Phenylephrine—Arrhythmia—Doxorubicin—bone cancer	0.00332	0.00335	CcSEcCtD
Phenylephrine—Nausea—Cisplatin—bone cancer	0.0033	0.00333	CcSEcCtD
Phenylephrine—Vision blurred—Epirubicin—bone cancer	0.0033	0.00333	CcSEcCtD
Phenylephrine—Mental disorder—Doxorubicin—bone cancer	0.00326	0.00329	CcSEcCtD
Phenylephrine—Agitation—Epirubicin—bone cancer	0.00321	0.00325	CcSEcCtD
Phenylephrine—Chest pain—Methotrexate—bone cancer	0.00318	0.00321	CcSEcCtD
Phenylephrine—Tension—Doxorubicin—bone cancer	0.00318	0.00321	CcSEcCtD
Phenylephrine—Dysgeusia—Doxorubicin—bone cancer	0.00317	0.0032	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00316	0.00319	CcSEcCtD
Phenylephrine—Nervousness—Doxorubicin—bone cancer	0.00314	0.00317	CcSEcCtD
Phenylephrine—Syncope—Epirubicin—bone cancer	0.00314	0.00317	CcSEcCtD
Phenylephrine—Palpitations—Epirubicin—bone cancer	0.00309	0.00312	CcSEcCtD
Phenylephrine—Loss of consciousness—Epirubicin—bone cancer	0.00307	0.0031	CcSEcCtD
Phenylephrine—Vision blurred—Doxorubicin—bone cancer	0.00305	0.00308	CcSEcCtD
Phenylephrine—Hypertension—Epirubicin—bone cancer	0.00302	0.00305	CcSEcCtD
Phenylephrine—Epinephrine—CYP3A4—bone cancer	0.00301	0.311	CrCbGaD
Phenylephrine—Nervous system disorder—Methotrexate—bone cancer	0.00299	0.00302	CcSEcCtD
Phenylephrine—Chest pain—Epirubicin—bone cancer	0.00298	0.00301	CcSEcCtD
Phenylephrine—Agitation—Doxorubicin—bone cancer	0.00297	0.003	CcSEcCtD
Phenylephrine—Skin disorder—Methotrexate—bone cancer	0.00296	0.00299	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00296	0.00299	CcSEcCtD
Phenylephrine—Hyperhidrosis—Methotrexate—bone cancer	0.00295	0.00298	CcSEcCtD
Phenylephrine—Syncope—Doxorubicin—bone cancer	0.0029	0.00293	CcSEcCtD
Phenylephrine—Palpitations—Doxorubicin—bone cancer	0.00286	0.00289	CcSEcCtD
Phenylephrine—Loss of consciousness—Doxorubicin—bone cancer	0.00284	0.00287	CcSEcCtD
Phenylephrine—Shock—Epirubicin—bone cancer	0.00281	0.00284	CcSEcCtD
Phenylephrine—Nervous system disorder—Epirubicin—bone cancer	0.0028	0.00283	CcSEcCtD
Phenylephrine—Hypertension—Doxorubicin—bone cancer	0.00279	0.00282	CcSEcCtD
Phenylephrine—Tachycardia—Epirubicin—bone cancer	0.00279	0.00281	CcSEcCtD
Phenylephrine—Skin disorder—Epirubicin—bone cancer	0.00277	0.0028	CcSEcCtD
Phenylephrine—Hyperhidrosis—Epirubicin—bone cancer	0.00276	0.00279	CcSEcCtD
Phenylephrine—Chest pain—Doxorubicin—bone cancer	0.00276	0.00278	CcSEcCtD
Phenylephrine—Paraesthesia—Methotrexate—bone cancer	0.00274	0.00277	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00274	0.00276	CcSEcCtD
Phenylephrine—Dyspnoea—Methotrexate—bone cancer	0.00272	0.00275	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Methotrexate—bone cancer	0.00263	0.00266	CcSEcCtD
Phenylephrine—Pain—Methotrexate—bone cancer	0.00261	0.00263	CcSEcCtD
Phenylephrine—Shock—Doxorubicin—bone cancer	0.0026	0.00262	CcSEcCtD
Phenylephrine—Nervous system disorder—Doxorubicin—bone cancer	0.00259	0.00262	CcSEcCtD
Phenylephrine—Tachycardia—Doxorubicin—bone cancer	0.00258	0.0026	CcSEcCtD
Phenylephrine—Skin disorder—Doxorubicin—bone cancer	0.00257	0.00259	CcSEcCtD
Phenylephrine—Paraesthesia—Epirubicin—bone cancer	0.00256	0.00259	CcSEcCtD
Phenylephrine—Hyperhidrosis—Doxorubicin—bone cancer	0.00255	0.00258	CcSEcCtD
Phenylephrine—Dyspnoea—Epirubicin—bone cancer	0.00255	0.00257	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Epirubicin—bone cancer	0.00246	0.00249	CcSEcCtD
Phenylephrine—Pain—Epirubicin—bone cancer	0.00244	0.00247	CcSEcCtD
Phenylephrine—Urticaria—Methotrexate—bone cancer	0.00242	0.00245	CcSEcCtD
Phenylephrine—Paraesthesia—Doxorubicin—bone cancer	0.00237	0.0024	CcSEcCtD
Phenylephrine—Dyspnoea—Doxorubicin—bone cancer	0.00236	0.00238	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00228	0.0023	CcSEcCtD
Phenylephrine—Urticaria—Epirubicin—bone cancer	0.00227	0.00229	CcSEcCtD
Phenylephrine—Pain—Doxorubicin—bone cancer	0.00226	0.00228	CcSEcCtD
Phenylephrine—Hypersensitivity—Methotrexate—bone cancer	0.00225	0.00227	CcSEcCtD
Phenylephrine—Pruritus—Methotrexate—bone cancer	0.00216	0.00218	CcSEcCtD
Phenylephrine—Hypersensitivity—Epirubicin—bone cancer	0.0021	0.00212	CcSEcCtD
Phenylephrine—Urticaria—Doxorubicin—bone cancer	0.0021	0.00212	CcSEcCtD
Phenylephrine—Pruritus—Epirubicin—bone cancer	0.00202	0.00204	CcSEcCtD
Phenylephrine—Dizziness—Methotrexate—bone cancer	0.00202	0.00204	CcSEcCtD
Phenylephrine—Hypersensitivity—Doxorubicin—bone cancer	0.00195	0.00197	CcSEcCtD
Phenylephrine—Vomiting—Methotrexate—bone cancer	0.00194	0.00196	CcSEcCtD
Phenylephrine—Rash—Methotrexate—bone cancer	0.00192	0.00194	CcSEcCtD
Phenylephrine—Dermatitis—Methotrexate—bone cancer	0.00192	0.00194	CcSEcCtD
Phenylephrine—Headache—Methotrexate—bone cancer	0.00191	0.00193	CcSEcCtD
Phenylephrine—Dizziness—Epirubicin—bone cancer	0.00189	0.00191	CcSEcCtD
Phenylephrine—Pruritus—Doxorubicin—bone cancer	0.00187	0.00189	CcSEcCtD
Phenylephrine—Vomiting—Epirubicin—bone cancer	0.00182	0.00183	CcSEcCtD
Phenylephrine—Nausea—Methotrexate—bone cancer	0.00181	0.00183	CcSEcCtD
Phenylephrine—Rash—Epirubicin—bone cancer	0.0018	0.00182	CcSEcCtD
Phenylephrine—Dermatitis—Epirubicin—bone cancer	0.0018	0.00182	CcSEcCtD
Phenylephrine—Headache—Epirubicin—bone cancer	0.00179	0.00181	CcSEcCtD
Phenylephrine—Dizziness—Doxorubicin—bone cancer	0.00175	0.00176	CcSEcCtD
Phenylephrine—Nausea—Epirubicin—bone cancer	0.0017	0.00171	CcSEcCtD
Phenylephrine—Vomiting—Doxorubicin—bone cancer	0.00168	0.0017	CcSEcCtD
Phenylephrine—Rash—Doxorubicin—bone cancer	0.00167	0.00168	CcSEcCtD
Phenylephrine—Dermatitis—Doxorubicin—bone cancer	0.00166	0.00168	CcSEcCtD
Phenylephrine—Headache—Doxorubicin—bone cancer	0.00165	0.00167	CcSEcCtD
Phenylephrine—Nausea—Doxorubicin—bone cancer	0.00157	0.00158	CcSEcCtD
